L'Oréal -backed biotech firm Debut has released an artificial intelligence (AI)-powered ingredient discovery platform aimed at the beauty industry. BeautyORB works to discover novel ingredients and ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

BioNTech SE (NASDAQ:BNTX), a biotechnology company renowned for its mRNA technology platform and COVID-19 vaccine success, is navigating a crucial phase in its evolution. With a market capitalization ...

By reducing the cost of breeding, the firm hopes to improve yields and other properties for an array of important crops ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Natural insecticide developer has won $3 million of US military grants to tackle the problems of mosquito-borne diseases, ...

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...